Nucleic Acids Research Advance Access originally published online on August 16, 2006
Nucleic Acids Research 2006 34(14):4000-4011; doi:10.1093/nar/gkl505
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nucleic Acids Research, 2006, Vol. 34, No. 14 4000-4011
© 2006 The Author(s).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Molecular Biology |
A region of human BRCA2 containing multiple BRC repeats promotes RAD51-mediated strand exchange
Cancer Research UK Department of Oncology and The Medical Research Council Cancer Cell Unit, Hutchison/MRC Research Centre, University of Cambridge Hills Road, Cambridge CB2 2XZ, UK 1 Department of Biochemistry, University of Cambridge Tennis Court Road, Cambridge CB2 1GA, UK
*To whom correspondence should be addressed. Ashok R. Venkitaraman, Hutchison/MRC Research Centre, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK. Tel: +44 1223 336901; Fax: +44 1223 763374; Email: arv22{at}cam.ac.uk
Received May 2, 2006. Revised June 28, 2006. Accepted July 3, 2006.
Human BRCA2, a breast and ovarian cancer suppressor, binds to the DNA recombinase RAD51 through eight conserved BRC repeats, motifs of 
30 residues, dispersed across a large region of the protein. BRCA2 is essential for homologous recombination in vivo, but isolated BRC repeat peptides can prevent the assembly of RAD51 into active nucleoprotein filaments in vitro, suggesting a model in which BRCA2 sequesters RAD51 in undamaged cells, and promotes recombinase function after DNA damage. How BRCA2 might fulfill these dual functions is unclear. We have purified a fragment of human BRCA2 (BRCA2BRC1–8) with 1127 residues spanning all 8 BRC repeats but excluding the C-terminal DNA-binding domain (BRCA2CTD). BRCA2BRC1–8 binds RAD51 nucleoprotein filaments in a ternary complex, indicating it may organize RAD51 on DNA. Human RAD51 is relatively ineffective in vitro at strand exchange between homologous DNA molecules unless non-physiological ions like 
are present. In an ionic milieu more typical of the mammalian nucleus, BRCA2BRCI–8 stimulates RAD51-mediated strand exchange, suggesting it may be an essential co-factor in vivo. Thus, the human BRC repeats, embedded within their surronding sequences as an eight-repeat unit, mediate homologous recombination independent of the BRCA2CTD through a previously unrecognized role in control of RAD51 activity.
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Rajendra and A. R. Venkitaraman Two modules in the BRC repeats of BRCA2 mediate structural and functional interactions with the RAD51 recombinase Nucleic Acids Res., October 29, 2009; (2009) gkp873v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. K. Shivji, S. R. Mukund, E. Rajendra, S. Chen, J. M. Short, J. Savill, D. Klenerman, and A. R. Venkitaraman The BRC repeats of human BRCA2 differentially regulate RAD51 binding on single- versus double-stranded DNA to stimulate strand exchange PNAS, August 11, 2009; 106(32): 13254 - 13259. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C. Burgess, M. Lisby, V. Altmannova, L. Krejci, P. Sung, and R. Rothstein Localization of recombination proteins and Srs2 reveals anti-recombinase function in vivo J. Cell Biol., June 15, 2009; 185(6): 969 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Zhou, M. Kojic, and W. K. Holloman DNA-binding Domain within the Brh2 N Terminus Is the Primary Interaction Site for Association with DNA J. Biol. Chem., March 27, 2009; 284(13): 8265 - 8273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Evers, R. Drost, E. Schut, M. de Bruin, E. van der Burg, P. W.B. Derksen, H. Holstege, X. Liu, E. van Drunen, H. B. Beverloo, et al. Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin Clin. Cancer Res., June 15, 2008; 14(12): 3916 - 3925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Mazloum, Q. Zhou, and W. K. Holloman D-loop formation by Brh2 protein of Ustilago maydis PNAS, January 15, 2008; 105(2): 524 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Adimoolam, M. Sirisawad, J. Chen, P. Thiemann, J. M. Ford, and J. J. Buggy HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination PNAS, December 4, 2007; 104(49): 19482 - 19487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. I. R. Petalcorin, V. E. Galkin, X. Yu, E. H. Egelman, and S. J. Boulton Stabilization of RAD-51-DNA filaments via an interaction domain in Caenorhabditis elegans BRCA2 PNAS, May 15, 2007; 104(20): 8299 - 8304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Zhou, M. Kojic, Z. Cao, M. Lisby, N. A. Mazloum, and W. K. Holloman Dss1 Interaction with Brh2 as a Regulatory Mechanism for Recombinational Repair Mol. Cell. Biol., April 1, 2007; 27(7): 2512 - 2526. [Abstract] [Full Text] [PDF]
|
|